Tacticity directed peptide systems for targeted drug delivery
No Thumbnail Available
Ever since Paul Ehrlich proposed the concept of “magic bullet”, the pharmaceutical sector has been on the lookout for that special molecule. However, with the reducing chemical universe and strict Food and Drug Administrator regulations, the drug discovery pipeline for new small molecular entities as potential drug candidates is drying. Further, it has also led to the increase in the research and development costs involved in the development of a novel drug candidate. Therefore, pharmaceutical industry is more absorbed towards the development of peptide-based drug therapies in recent times. At such a critical juncture, the pharmaceutical industry is also open to discovering new avenues for drug repurposing and designing therapies using existing drug molecules. Peptides offer a wide source of novel therapeutic molecules and therapies owing to the distinct probabilities of chemical sequence combinations. Moreover, peptides also provide ample chemistry for the attachment of multiple molecules through simple chemical reactions. Given the biological origin against traditional chemical nature of existing drugs, it also offers avenues for better biocompatibility and a reduced post action toxicity. Cell penetrating peptides (CPPs) are short peptides which have the ability to pass through the cell membrane while maintaining low levels of toxicity. The uptake of CPPs may be an energy dependent or independent process and does not involve chiral recognition by specific cellular receptors. Since the discovery of the transducing capabilities of the Tat peptide in 1988, many peptides capable of cell penetration have been discovered and designed. They have been utilized for transporting various cargoes: small molecules, nanoparticles, nucleic acids liposomes and proteins inside the cells and thus, show promising application as drug delivery vehicles.
Supervisor: Vibin Ramakrishnan and Vishal Trivedi
BIOSCIENCES AND BIOENGINEERING